Related Experiment Videos
Conformational analysis of optically active phenylethylamines and phenylimidazolines
M G Cardozo1, M T Pizzorno, A B Pierini
1IQUIMEFA, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, Argentina.
Drug Design and Delivery
|December 1, 1988
Summary
Phenethylamine and phenylimidazoline derivatives exhibit distinct conformations and interact with different sites, though both require a cationic recognition site for alpha-adrenergic activity.
Area of Science:
- Medicinal Chemistry
- Computational Chemistry
- Pharmacology
Background:
- Phenethylamine and phenylimidazoline derivatives are known to possess alpha-adrenergic activity.
- Understanding their conformational and structural features is crucial for drug design.
Purpose of the Study:
- To investigate the conformational and structural characteristics of phenethylamine and phenylimidazoline derivatives.
- To elucidate the interaction sites responsible for their alpha-adrenergic activity.
Main Methods:
- Utilized Modified Neglect of Differential Overlap (MNDO) and Perturbative Interior Maximum Configuration Interaction (PCILO) computational methods.
- Generated and analyzed conformational energy maps for both compound classes.
Main Results:
- Phenethylamines adopt an extended conformation.
- Phenylimidazolines display an intermediate conformation between extended and folded states.
- Phenethylamines interact with Easson-Stedman sites, while phenylimidazolines bind to a distinct site.
- Both compound classes demonstrate a requirement for a cationic recognition site.
Conclusions:
- Conformational differences dictate distinct binding interactions for phenethylamines and phenylimidazolines.
- A shared cationic recognition site is essential for the alpha-adrenergic activity of both derivative types.